secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0000927653-24-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson FQ3 revenue $80.9B (+15% YoY), adjusted EPS $7.74 (+12%), raises FY guidance
--------------------------------------------------------------------------------

- Revenue $80.9B up 15% YoY; GAAP EPS from continuing ops $4.42 vs $7.65 (down 42%).
- Adjusted EPS $7.74 vs $6.90; adjusted earnings $1,032M up 6%.
- FY 2024 adjusted EPS guidance raised to $27.25-$27.65 from $26.80-$27.40.
- US Oncology Network added Nashville Oncology Associates and SCRI Oncology Partners.
- Year-to-date revenue $232.6B (+12%); adjusted EPS $21.24 (+13%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/0000927653-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765324000018/mck-20240207.htm
  HTML page:      https://secwatch.observer/filing/0000927653-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer